<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
  <title>GIDS Research Radar · Peru</title>
  <link>https://globalinfectiousdisease.com/research/</link>
  <description>Published infectious-disease literature filtered to Peru.</description>
  <language>en</language>
  <atom:link href="https://globalinfectiousdisease.com/research/rss/countries/pe.xml" rel="self" type="application/rss+xml" />
  <lastBuildDate>Wed, 09 Sep 2026 07:02:01 GMT</lastBuildDate>
  <item>
    <title>Independent clinic-based evaluation of dual POCTs for screening for HIV and syphilis in men who have sex with men in Italy, Malta, Peru, and the United Kingdom</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09019-3-5bf76d5e/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1186-s12879-024-09019-3-5bf76d5e/</guid>
    <pubDate>Thu, 29 Feb 2024 00:00:00 GMT</pubDate>
    <description>Dual point-of-care tests could serve as a cost-effective, patient-friendly, and provider-friendly alternative to conventional testing in clinical and field settings, particularly in resource-limited environments where validated screening tools may help reduce HIV and syphilis incidence.</description>
    <category>Syphilis</category>
    <category>AIDS</category>
    <category>Diagnostics</category>
    <category>Treatment</category>
    <category>Meta-analysis</category>
  </item>
  <item>
    <title>Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1038-s41541-023-00630-0-71b194cd/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1038-s41541-023-00630-0-71b194cd/</guid>
    <pubDate>Sat, 11 Mar 2023 00:00:00 GMT</pubDate>
    <description>Establishing quantitative immunological benchmarks may assist regulatory agencies in evaluating vaccine performance during approval pathways.</description>
    <category>COVID-19</category>
    <category>SARS</category>
    <category>Vaccination</category>
    <category>Outbreak investigation</category>
    <category>Vaccine effectiveness</category>
    <category>Randomised controlled trial</category>
  </item>
  <item>
    <title>Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1016-s2666-5247-20-30197-x-4258082a/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1016-s2666-5247-20-30197-x-4258082a/</guid>
    <pubDate>Mon, 01 Feb 2021 00:00:00 GMT</pubDate>
    <description>Multiplex serological approaches offer potential solutions for classifying individuals infected more than six months prior and for measuring seroprevalence in very low-transmission settings, addressing key challenges in SARS-CoV-2 serological surveillance.</description>
    <category>SARS</category>
    <category>COVID-19</category>
    <category>Diagnostics</category>
    <category>Surveillance</category>
    <category>Transmission dynamics</category>
    <category>Mathematical modelling</category>
  </item>
  <item>
    <title>Incomplete Protection against Dengue Virus Type 2 Re-infection in Peru</title>
    <link>https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0004398-83d7ad4d/</link>
    <guid isPermaLink="true">https://globalinfectiousdisease.com/research/articles/10-1371-journal-pntd-0004398-83d7ad4d/</guid>
    <pubDate>Fri, 05 Feb 2016 00:00:00 GMT</pubDate>
    <description>The findings challenge the assumption of complete lifelong protection from homologous dengue re-infection and provide context for understanding limited vaccine efficacy against DENV-2 in recent trials. The incomplete protection may have implications for dengue transmission dynamics.</description>
    <category>Dengue</category>
    <category>Vaccination</category>
    <category>Journal article</category>
  </item>
</channel>
</rss>
